Skip to content
    OHI
    Earnings call· Mar 2026(Q1 FY26)

    OMEGA HEALTHCARE INVESTORS Q1 FY26 earnings call OHI

    Apr 29, 2026 Source

    Executive summary

    Omega Healthcare Investors Q1 FY26 — Strong AFFO/FAD Growth and Strategic Capital Allocation

    Omega Healthcare Investors reported a strong Q1 FY26, driven by strategic acquisitions and active portfolio management, leading to robust AFFO and FAD per share growth. The company successfully executed a significant asset disposition to enhance credit and redeploy capital, while also expanding its RIDEA platform and pursuing off-market opportunities in both U.S. and U.K. markets. Management expressed confidence in continued FAD growth and potential dividend conversations by year-end, supported by a strong balance sheet and active pipeline.

    Highlights

    5

    • Adjusted FFO of $0.82 per share and FAD of $0.78 per share, reflecting strong revenue and EBITDA growth.

    • FAD per share increased 9.5% over the same quarter last year.

    • Trailing 12-month operator EBITDAR coverage reached 1.58x, the highest in over a decade.

    • Strategic sale of 18 Communicare assets for $480 million at a blended 7.7% rent discount, enhancing credit and realizing significant value.

    • Full-year AFFO guidance midpoint raised by $0.02 to $3.22 per share.

    Concerns

    1

    • No material negative concerns were explicitly quantified or highlighted as significant headwinds during the call.

    Guidance & targets

    1
    CategoryTargetConfidence
    Full-year Adjusted FFO per share
    $3.19 to $3.25 per share
    high materiality
    High

    Operational metrics

    32
    Adjusted FFO per share
    $0.82$0.02 greater than Q4 FY25
    Q1 FY26

    Reflects strong revenue and EBITDA growth, principally fueled by acquisitions and active portfolio management.

    FAD per share
    $0.78$0.02 greater than Q4 FY25
    Q1 FY26

    Reflects strong revenue and EBITDA growth, principally fueled by acquisitions and active portfolio management.

    Dividend payout ratio
    82%
    Q1 FY26
    Dividend payout ratio
    86%
    Q1 FY26
    FAD per share growth
    9.5%YoY
    Q1 FY26

    Increase over the same quarter last year.

    Annual AFFO and FAD accretion from capital redeployment
    $0.03
    Annual

    Management noted the number was conservative, with actual accretion potentially higher (e.g., $0.035 to $0.04 if reinvested at 10% yield).

    New investments
    $326M
    YTD FY26

    Transaction activity started strong.

    New investments
    $251M
    Q1 FY26

    Not including $13 million in CapEx.

    Capital expenditure
    $13M
    Q1 FY26

    In addition to new investments.

    Real estate loans
    $27M
    Q1 FY26

    Part of other first quarter investments.

    Weighted average yield on leases and loans
    10.9%
    Q1 FY26

    For new investments completed in Q1 FY26.

    New investments (subsequent to quarter end)
    $75M
    Subsequent to Q1 FY26

    Closed additional investments.

    Lease yield
    10%
    Q2 FY26

    For 2 Indiana skilled nursing facilities leased to a current Omega operator.

    Target IRR for pipeline deals
    mid-teens
    Future

    For deals in the pipeline, particularly senior housing RIDEA.

    Asset sales
    $53M
    Q4 FY25 and Q1 FY26

    Partially offset incremental net income from new investments.

    Q1 rent from Communicare facilities sold
    $9.2M
    Q1 FY26

    Total rent related to the assets held for sale.

    Borrowings on credit facility
    $425M
    As of March 31, 2026
    Available cash
    $26M
    As of March 31, 2026
    Available capacity on revolver
    $1.5B
    As of March 31, 2026
    Next scheduled debt maturity
    April 2027
    Future
    Fixed charge coverage ratio
    6.3x
    Q1 FY26
    Leverage
    3.5xflat
    Q1 FY26

    Remained flat at quarter end.

    DIP loan funding commitment
    $26.7M
    March 2026
    DIP loan funded portion
    $25M
    End of Q1 FY26
    Loan repayments
    $88M
    Q4 FY25 and Q1 FY26

    Partially offset incremental net income from new investments.

    Mortgages and other real estate loans maturing in 2026
    $159M
    FY26

    Expected to mature in 2026.

    Mortgages and other real estate loans converting to fee simple
    $65M
    FY26

    Assumed to convert to fee simple real estate out of $159M maturing loans.

    Non-real estate backed loans expected to be repaid
    $224M
    FY26

    As of March 31, 2026, expected to be repaid throughout 2026.

    Genesis loans expected to be repaid
    $159.5M
    FY26

    Included in the $224M non-real estate backed loans.

    Annual escalators
    $2M
    Annual

    Revenue from annual escalators.

    Common shares and OP units issued
    7.7M
    Q4 FY25 and Q1 FY26

    Issued to fund new investments.

    Maplewood net rate increases
    high single-digit
    Q1 FY26

    Across the portfolio.

    Industry KPIs

    5
    MetricValueDetails
    Revpor growthhigh single-digit%
    Coverage ratios1.58xx
    Senior housing occupancyincrease
    Operator tenant concentration—
    Investment volume and sourcing mix$326MUSD

    Deals & partnerships

    7
    CommunicareStrategic sale of 18 skilled nursing facilities$480M

    18 assets located in Maryland and West Virginia. 12 Maryland facilities sold subsequent to quarter end. Remaining 6 West Virginia facilities expected to be sold in Q2. Rent discount at a blended 7.7%. Sale aimed at enhancing credit with Communicare and realizing significant value.

    SaberEquity investment in Saber's operating company

    Purchase of 9.9% of the equity interest in Saber's operating company. Saber plans to continue growing through accretive transactions.

    UndisclosedAcquisition of 13 Georgia skilled nursing facilities$109M

    Part of Q1 FY26 new investments.

    UndisclosedInvestment in Alabama Senior Housing RIDEA transaction$10M

    Part of Q1 FY26 new investments.

    UndisclosedPurchase of a U.K. care home$7M

    Part of Q1 FY26 new investments.

    Current Omega operatorPurchase of 2 Indiana skilled nursing facilities$33M

    Closed subsequent to quarter end. Facilities will be leased to a current Omega operator.

    Third-party managerPurchase of 3 senior housing facilities in Rhode Island$42M

    Closed subsequent to quarter end. Facilities will be operated by Omega and managed by a third-party manager via RIDEA structure. Underwritten to stabilize mid-teen IRRs.

    Risks & headwinds

    3
    Medicare Advantage impact on operator businessOngoing

    Rates sometimes materially lower than Medicare, high denial rates, delayed payments.

    Mitigation: Industry pushback to increase rates, legislation introduced to address issues. Omega partners with sophisticated operators.

    Competitiveness in SNF and Senior Housing RIDEA transaction marketsOngoing

    Heavily competitive in SNF space, many players in senior housing RIDEA.

    Mitigation: Omega remains disciplined, selective, and creative in structuring deals. Focus on off-market deals through relationships. Finding value-add products that meet investment criteria.

    Litigation risk for REITs in operationsOngoing

    Reference to a one-off unique situation where a REIT was held culpable for patient care.

    Mitigation: Omega believes it does not get involved in operations or patient care. Will continue to watch various areas and ensure it's part of investment thesis.

    What to watch in Q2 FY26

    4

    Communicare asset sales completion

    Q2 FY26
    Current12 of 18 facilities sold
    TargetRemaining 6 West Virginia facilities sold

    Why it matters

    Completion of sales will finalize the capital for redeployment and impact future AFFO/FAD accretion.

    Subsequent to quarter end, 12 Maryland facilities were sold, and we expect the remaining 6 West Virginia facilities to be sold in the second quarter.

    Q&A highlights

    5

    What was the rationale behind the Communicare asset sales, and do they indicate broader market conditions in Maryland and West Virginia?

    The sale was opportunistic, driven by a fair bid and the ability to enhance credit with Communicare. While Maryland and West Virginia are currently hot markets, this is not expected to be a core part of Omega's capital allocation strategy, and no large dispositions are anticipated in the next few quarters.

    “the primary reason for the disposition was opportunistic. We had an opportunity to sell assets and enhance our credit with Communicare. We were able to get a bid that we thought was fair to both parties.”

    asked by Unknown Analyst · answered by Matthew Gourmand

    2 min read6 chapters

    Detailed Narrative

    01

    Q1 Financial Performance Overview

    Omega Healthcare Investors reported Q1 FY26 revenue of $323 million, up from $277 million in Q1 FY25, primarily due to new investments and annual escalators. Net income for the quarter was $159 million, or $0.47 per common share, compared to $112 million, or $0.33 per common share, in Q1 FY25. Adjusted FFO was $0.82 per share and FAD was $0.78 per share, both $0.02 higher than Q4 FY25, driven by $585 million in new investments and $2 million from annual escalators, partially offset by $53 million in asset sales and $88 million in loan repayments.

    02

    Strategic Asset Sales and Capital Redeployment

    The company is in the process of selling 18 Communicare assets in Maryland and West Virginia for a contractual purchase price of $480 million, at a blended rent discount of 7.7%. Twelve Maryland facilities were sold subsequent to quarter-end, with the remaining six West Virginia facilities expected to close in Q2. This strategic disposition is anticipated to result in approximately $0.03 of annual AFFO and FAD accretion through capital redeployment, with management aiming for yields in the low 9s to 10s on reinvested capital.

    03

    Investment Activity and Pipeline

    Omega completed $326 million in new investments year-to-date, including $251 million in Q1 FY26 and an additional $75 million subsequent to quarter-end. Q1 investments included a $109 million acquisition of 13 Georgia skilled nursing facilities, a $10 million Alabama Senior Housing RIDEA transaction, a $7 million UK care home purchase, and $27 million in real estate loans, with a weighted average yield of 10.9%. The pipeline focuses on U.S. senior housing RIDEA, U.S. skilled nursing, and U.K. care homes, targeting mid-teen IRRs.

    04

    Balance Sheet Strength and Liquidity

    The company maintains a strong balance sheet with $425 million in credit facility borrowings, $26 million in available cash, and over $1.5 billion in available capacity on its $2 billion revolver. The next scheduled debt maturity is in April 2027. The fixed charge coverage ratio stood at 6.3x, and leverage remained flat at 3.5x, positioning Omega to fund its active pipeline accretively.

    05

    Genesis Bankruptcy Update

    The Genesis bankruptcy process is progressing, with Omega committing to fund up to $26.7 million (one-third of an $80 million DIP loan), having funded $25 million of its initial $75 million advance. The company anticipates its Genesis master lease will be assumed by 101 West State Street, and its DIP loan and term loan will be repaid at closing, with confidence that the term loan is fully collateralized.

    06

    Medicare Advantage and Occupancy Trends

    Medicare Advantage penetration in skilled nursing remains relatively low, but industry efforts are underway to address issues like low rates and high denial rates. While occupancy trends have stagnated over the past few quarters, management attributes this to short-term fluctuations, expecting an increase in the next year or two driven by favorable demographics and limited new supply. The current operator coverage provides ample rent coverage.

    AI-generated summary of the company’s earnings call. Not investment advice.